COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 39 filers reported holding COMPASS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $604,047 | +16.2% | 306,623 | +87.6% | 0.00% | – |
| Q2 2023 | $519,822 | +16149.5% | 163,466 | -83.3% | 0.00% | -100.0% |
| Q1 2023 | $3,199 | +676.5% | 978,403 | +1093.9% | 0.00% | – |
| Q4 2022 | $412 | -99.7% | 81,947 | +29.7% | 0.00% | – |
| Q3 2022 | $144,000 | +94.6% | 63,187 | +126.8% | 0.00% | – |
| Q2 2022 | $74,000 | +39.6% | 27,861 | -27.7% | 0.00% | – |
| Q1 2022 | $53,000 | +51.4% | 38,545 | +245.5% | 0.00% | – |
| Q4 2021 | $35,000 | – | 11,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |